Search

everythinglearnresearchcommunity

for

Search:↓

Home-use lasers and IPL devices are unlikely to directly cause paradoxical hair growth; it may be linked to inflammation or hormonal issues.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Arg1+ macrophages may play a role in causing alopecia areata.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Tofacitinib helped regrow hair in a teen with a unique pattern of alopecia areata.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

FOXN1 mutations cause severe immunodeficiency, hair loss, nail issues, and thymus defects.

Heat treatment increases hair loss in certain mice.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Special cells can help regrow hair in alopecia areata.

Squaric acid dibutylester promotes hair growth by activating immune cells, especially macrophages.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Cortisone tapering may help improve severe myasthenia gravis and alopecia areata after thymectomy.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Light therapy is effective and safe for treating skin color disorders like vitiligo and dark spots.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

Females generally have stronger immune responses than males due to the X chromosome.